Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/ekelCfbwocfblTwFSnPV

February 12, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Stories 
  • ACA rules on EHBs, insurer losses headed to White House
    Two major Affordable Care Act rules have been sent to the White House for final review. The administration will consider a rule that sets standards for essential health benefits and a timeline for the accreditation of health plans for exchanges. The second rule concerns the protection of insurers against financial losses. The Hill (2/11) LinkedInFacebookTwitterEmail this Story
  Legislative & Regulatory News 
  • HHS says fraud recovery efforts pay off
    HHS and the Justice Department recovered $4.2 billion in the last fiscal year from people attempting to defraud Medicare and Medicaid, HHS Secretary Kathleen Sebelius and Attorney General Eric Holder announced. Each dollar spent over the past three years investigating fraud yielded $7.90, according to a joint report. Reuters (2/11), USA Today (2/12) LinkedInFacebookTwitterEmail this Story
  • Spending on health care rose 4.3% in 2012
    Research by the Altarum Institute's Center for Sustainable Health Spending found that health care spending in 2012 went up 4.3%. "While slightly above the flat three-year experience of 3.9%, our data demonstrates continued historically low health care spending growth," Altarum's Charles Roehrig said. Health care prices rose the least since 1998, inching up 1.7% from December 2011 to December 2012. BenefitsPro.com (2/8) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • Footnote in court brief hints at new FDA rules for generic warnings
    The FDA may revise regulations so that makers of generic drugs can update labels to warn patients about risks, Ed Silverman writes. The Justice Department filed a friend-of-the-court brief in a case concerning generic drugs, and it carried this footnote: "This office has been informed that FDA is considering a regulatory change that would allow generic manufacturers, like brand-name manufacturers, to change their labeling in appropriate circumstances." Pharmalot.com/Pharma Blog (2/11) LinkedInFacebookTwitterEmail this Story
  SmartQuote 
We spend our time searching for security and hate it when we get it."
--John Steinbeck,
American author


LinkedInFacebookTwitter

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

 
Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
 
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 
 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information